Cheng Danni, Qiu Ke, Li Daibo, Mao Minzi, Rao Yufang, Song Yao, Feng Lan, Shao Xiuli, Jiang Chuanhuan, Wang Yan, Li Li, Chen Xuemei, Wu Sisi, Wang Haiyang, Liu Jun, Yu Haopeng, Zhang Wei, Chen Fei, Zhao Yu, Ren Jianjun
Department of Oto-Rhino-Laryngology West China Hospital, Sichuan University Chengdu Sichuan China.
Research Core Facility West China Hospital Sichuan University Chengdu China.
MedComm (2020). 2024 Jun 12;5(6):e572. doi: 10.1002/mco2.572. eCollection 2024 Jun.
Tumor-infiltrating CD4 T cells orchestrate the adaptive immune response through remarkable plasticity, and the expression patterns of exhaustion-related inhibitory receptors in these cells differ significantly from those of CD8 T cells. Thus, a better understanding of the molecular basis of CD4 T cell exhaustion and their responses to immune checkpoint blockade (ICB) is required. Here, we integrated multiomics approaches to define the phenotypic and molecular profiles of exhausted CD4 T cells in oropharyngeal squamous cell carcinoma (OPSCC). Two distinct immune-promoting (Module 1) and immunosuppressive (Module 2) functional modules in tumor-infiltrating CD4 T cells were identified, and both the immune-promoting function of Module 1 cells and immunosuppressive function of Module 2 cells were positively associated with their corresponding exhaustion states. Furthermore, the application of ICBs targeting effector CD4 T cells in Module 1 (αPD-1) and Treg cells in Module 2 (αCTLA-4) in mouse models could help reinvigorate the effector function of Module 1-exhausted CD4 T cells and reduce the immunosuppressive function of Module 2-exhausted CD4 T cells, ultimately promoting OPSCC tumor regression. Taken together, our study provides a crucial cellular basis for the selection of optimal ICB in treating OPSCC.
肿瘤浸润性CD4 T细胞通过显著的可塑性协调适应性免疫反应,这些细胞中耗竭相关抑制性受体的表达模式与CD8 T细胞有显著差异。因此,需要更好地理解CD4 T细胞耗竭的分子基础及其对免疫检查点阻断(ICB)的反应。在此,我们整合了多组学方法来定义口咽鳞状细胞癌(OPSCC)中耗竭CD4 T细胞的表型和分子特征。在肿瘤浸润性CD4 T细胞中鉴定出两个不同的免疫促进(模块1)和免疫抑制(模块2)功能模块,模块1细胞的免疫促进功能和模块2细胞的免疫抑制功能均与其相应的耗竭状态呈正相关。此外,在小鼠模型中应用针对模块1中的效应CD4 T细胞(αPD-1)和模块2中的调节性T细胞(αCTLA-4)的ICB,有助于恢复模块1耗竭CD4 T细胞的效应功能,并降低模块2耗竭CD4 T细胞的免疫抑制功能,最终促进OPSCC肿瘤消退。综上所述,我们的研究为选择治疗OPSCC的最佳ICB提供了关键的细胞基础。